Skip to main content
Equibles

Erste Asset Management GmbH

Position in IMVT — Immunovant, Inc.

CIK 2024532 VIENNA, C4
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$5,567,585
+$1,978,205 QoQ
Shares Held
144,500
0.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#52
of 226 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. IMVT ranks #22 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AGIO
Agios Pharmaceuticals, Inc.
 2,154,900 $79,968,339
2 MDGL
Madrigal Pharmaceuticals, Inc.
 110,210 $59,177,259
3 SRPT
Sarepta Therapeutics, Inc.
 2,568,945 $46,163,941
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 76,558 $38,028,654
5 ROIV
Roivant Sciences Ltd.
 834,000 $29,515,260
6 DNA
Ginkgo Bioworks Holdings, Inc.
 2,536,939 $25,141,065
7 REGN
Regeneron Pharmaceuticals, Inc.
 38,716 $24,140,974
8 MIRM
Mirum Pharmaceuticals, Inc.
 205,000 $23,999,350

All Filings in IMVT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,567,585 144,500
2026-03-31 $3,589,380 144,500
2025-12-31 $3,266,470 128,500
2025-09-30 $846,300 52,500
2025-06-30 $840,000 52,500
2025-03-31 $897,225 52,500
2024-12-31 $1,300,425 52,500
2024-09-30 $1,496,775 52,500
2024-06-30 $1,201,200 45,500
2024-03-31 $1,470,105 45,500
2023-12-31 $1,916,915 45,500